Astera Labs, Inc. Common Stock
NASDAQ:ALABSemiconductors
+$39.44 today
- Market cap
- $37.88B
- Beta
- 3.96
- P/E (TTM)
- 264.2
- EPS (TTM)
- $1.57
Volume 4.57M
Average 5.72M
ALAB EBITDA Margin
EBITDA as a percentage of revenue.
Astera Labs, Inc. Common StockNASDAQ: ALAB
EBITDA Margin · Q2 FY2026 · quarter ended Jun 2026
EBITDA Margin holds steady near 27.2%
EBITDA Margin was 27.2% in Q2 FY2026, up 0.1 pp from a year earlier. On a trailing-twelve-month basis it was 27.8%, up 13.0 pp year over year. Over 3 fiscal years it widened by 97.5 pp.
Context
- EBITDA Margin widened in 2 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 17 analysts of 50.0% for the fiscal year ending Dec 2026, up from 26.4% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- 27.2%+2.2 pp QoQ
- Last fiscal yearDec 2025
- 26.4%+46.2 pp YoY
- LTMJun 2026
- 27.8%+13.0 pp YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 26.4%
- Year-over-year change
- +46.2pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 26.4% | +46.2pp |
| FY2024 | 2024-12-31 | -19.8% | -1.6pp |
| FY2023 | 2023-12-31 | -18.3% | +52.8pp |
| FY2022 | 2022-12-31 | -71.1% | — |
EBITDA Margin vs competitors
How ALAB compares with its peers on the latest reported figures
- ALAB's LTM Jun 2026 EBITDA Margin of 27.8% is the 5th highest of the 7 companies compared; the peer median is 43.7%.
- Its year-over-year change of +13.0 pp is the 3rd highest of 7, against a peer median of +8.8 pp.
- Over three fiscal years its change of +97.5 pp compares with a peer median of +0.6 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Sep 2026 | 52.8% | +5.8 pp | -9.4 pp | |
| LTM Aug 2026 | 50.6% | +5.6 pp | -1.0 pp | |
| LTM Aug 2026 | 50.3% | +30.6 pp | +27.6 pp | |
| LTM Aug 2026 | 37.0% | +11.8 pp | +43.3 pp | |
| LTM Jun 2026 | 27.8% | +13.0 pp | +97.5 pp | |
| LTM Jun 2026 | 25.8% | +2.6 pp | +2.1 pp | |
| LTM Sep 2026 | 5.0% | +32.0 pp | -35.3 pp | |
| Peer median (excluding ALAB) | 43.7% | +8.8 pp | +0.6 pp | |
Competitors are the stored peer set for ALAB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Revenue | 79.87M | 115.79M | 396.29M | 852.53M |
| Cost of Revenue | 21.19M | 35.97M | 93.59M | 207.26M |
| Gross Profit | 58.68M | 79.83M | 302.7M | 645.26M |
| Gross Margin | 73.5% | 68.9% | 76.4% | 75.7% |
| Research & Development | 73.71M | 73.41M | 200.83M | 304M |
| Selling, General & Admin | 45.16M | 35.92M | 217.94M | 167.84M |
| Operating Expenses | 118.88M | 109.32M | 418.77M | 471.84M |
| Depreciation & Amortization | 807K | 1.78M | 3.15M | 6.83M |
| EBITDA | (56.77M) | (21.17M) | (78.62M) | 224.98M |
| EBITDA Margin | -71.1% | -18.3% | -19.8% | 26.4% |
| Operating Income | (60.19M) | (29.5M) | (116.07M) | 173.42M |
| Operating Margin | -75.4% | -25.5% | -29.3% | 20.3% |
| Interest Income | 2.61M | 6.55M | 34.29M | 44.73M |
| Interest Expense | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 2.61M | 6.55M | 34.29M | 44.73M |
| Income Before Tax | (57.58M) | (22.95M) | (81.78M) | 218.15M |
| Pre-Tax Margin | -72.1% | -19.8% | -20.6% | 25.6% |
| Income Tax Expense | 764K | 3.31M | 1.64M | (981K) |
| Net Income | (58.35M) | (26.26M) | (83.42M) | 219.13M |
| Net Margin | -73.0% | -22.7% | -21.1% | 25.7% |
| EPS (Basic) | (0.45) | (0.17) | (0.64) | 1.32 |
| EPS (Diluted) | (0.45) | (0.17) | (0.64) | 1.22 |
| Weighted Avg Shares | 130.45M | 152.5M | 131.26M | 166.41M |
| Weighted Avg Shares (Diluted) | 130.45M | 152.5M | 131.26M | 179.55M |
Astera Labs, Inc. Common Stock
NASDAQ:ALAB
Intrinsic Alpha fair value
Locked
Current Price
$216.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.